112 related articles for article (PubMed ID: 15572197)
1. Assessing activation of the human neuropeptide FF2 receptor with a non-radioactive GTP binding assay.
Engström M; Närvänen A; Savola JM; Wurster S
Peptides; 2004 Dec; 25(12):2099-104. PubMed ID: 15572197
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF(1) and NPFF(2)) receptors.
Talmont F; Garcia LP; Mazarguil H; Zajac JM; Mollereau C
Neurochem Int; 2009 Dec; 55(8):815-9. PubMed ID: 19682524
[TBL] [Abstract][Full Text] [Related]
3. Homogeneous GTP binding assay employing QRET technology.
Rozwandowicz-Jansen A; Laurila J; Martikkala E; Frang H; Hemmilä I; Scheinin M; Hänninen P; Härmä H
J Biomol Screen; 2010 Mar; 15(3):261-7. PubMed ID: 20103692
[TBL] [Abstract][Full Text] [Related]
4. A time-resolved fluorescent lanthanide (Eu)-GTP binding assay for chemokine receptors as targets in drug discovery.
Labrecque J; Wong RS; Fricker SP
Methods Mol Biol; 2009; 552():153-69. PubMed ID: 19513648
[TBL] [Abstract][Full Text] [Related]
5. Functional properties of Pfr(Tic)amide and BIBP3226 at human neuropeptide FF2 receptors.
Engström M; Wurster S; Savola JM; Panula P
Peptides; 2003 Dec; 24(12):1947-54. PubMed ID: 15127947
[TBL] [Abstract][Full Text] [Related]
6. The high throughput screening of neuropeptide FF2 receptor ligands from Korean herbal plant extracts.
Do EU; Piao LZ; Choi G; Choi YB; Kang TM; Shin J; Chang YJ; Nam HY; Kim HJ; Kim SI
Peptides; 2006 May; 27(5):997-1004. PubMed ID: 16488513
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.
Quelven I; Roussin A; Zajac JM
Eur J Pharmacol; 2005 Jan; 508(1-3):107-14. PubMed ID: 15680260
[TBL] [Abstract][Full Text] [Related]
8. Human kisspeptins activate neuropeptide FF2 receptor.
Lyubimov Y; Engstrom M; Wurster S; Savola JM; Korpi ER; Panula P
Neuroscience; 2010 Sep; 170(1):117-22. PubMed ID: 20600636
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of a human receptor for neuropeptide FF and related peptides.
Kotani M; Mollereau C; Detheux M; Le Poul E; Brézillon S; Vakili J; Mazarguil H; Vassart G; Zajac JM; Parmentier M
Br J Pharmacol; 2001 May; 133(1):138-44. PubMed ID: 11325803
[TBL] [Abstract][Full Text] [Related]
10. Europium-labeled GTP as a general nonradioactive substitute for [(35)S]GTPgammaS in high-throughput G protein studies.
Koval A; Kopein D; Purvanov V; Katanaev VL
Anal Biochem; 2010 Feb; 397(2):202-7. PubMed ID: 19849998
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterization of the mouse NPFF2 receptor.
Talmont F; Moulédous L; Piedra-Garcia L; Schmitt M; Bihel F; Bourguignon JJ; Zajac JM; Mollereau C
Peptides; 2010 Feb; 31(2):215-20. PubMed ID: 19944730
[TBL] [Abstract][Full Text] [Related]
12. Functional differences between NPFF1 and NPFF2 receptor coupling: high intrinsic activities of RFamide-related peptides on stimulation of [35S]GTPgammaS binding.
Gouardères C; Mazarguil H; Mollereau C; Chartrel N; Leprince J; Vaudry H; Zajac JM
Neuropharmacology; 2007 Feb; 52(2):376-86. PubMed ID: 17011599
[TBL] [Abstract][Full Text] [Related]
13. Neuropeptide FF receptors have opposing modulatory effects on nociception.
Lameh J; Bertozzi F; Kelly N; Jacobi PM; Nguyen D; Bajpai A; Gaubert G; Olsson R; Gardell LR
J Pharmacol Exp Ther; 2010 Jul; 334(1):244-54. PubMed ID: 20354177
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of neuropeptide FF and related peptidic and non-peptidic derivatives.
Vyas N; Mollereau C; Chevé G; McCurdy CR
Peptides; 2006 May; 27(5):990-6. PubMed ID: 16490282
[TBL] [Abstract][Full Text] [Related]
15. Study of the N-terminal part of peptidic selective NPFF₂ agonists.
Mazarguil H; Mollereau C; Czaplicki G; Zajac JM
Peptides; 2012 Sep; 37(1):157-60. PubMed ID: 22813580
[TBL] [Abstract][Full Text] [Related]
16. Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226.
Mollereau C; Gouardères C; Dumont Y; Kotani M; Detheux M; Doods H; Parmentier M; Quirion R; Zajac JM
Br J Pharmacol; 2001 May; 133(1):1-4. PubMed ID: 11325787
[TBL] [Abstract][Full Text] [Related]
17. Anti-analgesia of a selective NPFF2 agonist depends on opioid activity.
Roussin A; Serre F; Gouardères C; Mazarguil H; Roumy M; Mollereau C; Zajac JM
Biochem Biophys Res Commun; 2005 Oct; 336(1):197-203. PubMed ID: 16129413
[TBL] [Abstract][Full Text] [Related]
18. Regulation of endogenous human NPFF2 receptor by neuropeptide FF in SK-N-MC neuroblastoma cell line.
Ankö ML; Panula P
J Neurochem; 2006 Jan; 96(2):573-84. PubMed ID: 16336216
[TBL] [Abstract][Full Text] [Related]
19. Biochemical anti-opioid action of NPFF2 receptors in rat spinal cord.
Gouardères C; Zajac JM
Neurosci Res; 2007 May; 58(1):91-4. PubMed ID: 17337079
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells.
Mollereau C; Mazarguil H; Zajac JM; Roumy M
Mol Pharmacol; 2005 Mar; 67(3):965-75. PubMed ID: 15608144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
